[PDF] cell.comFull View

[PDF][PDF] The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer

H Wang, X Rong, G Zhao, Y Zhou, Y Xiao, D Ma, X Jin… - Cell metabolism, 2022 - cell.com
Immunotherapy has achieved limited success in patients with triple-negative breast cancer
(TNBC), an aggressive disease with a poor prognosis. Commensal microbiota have been …
被引用次数：135 相关文章

The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer

H Wang, X Rong, G Zhao, Y Zhou, Y Xiao, D Ma, X Jin… - paper.sciencenet.cn
Immunotherapy has achieved limited success in patients with triple-negative breastcancer
(TNBC), an aggressive disease with a poor prognosis. Commensal microbiota havebeen …

The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer.

H Wang, X Rong, G Zhao, Y Zhou, Y Xiao, D Ma… - Cell …, 2022 - europepmc.org
Immunotherapy has achieved limited success in patients with triple-negative breast cancer
(TNBC), an aggressive disease with a poor prognosis. Commensal microbiota have been …

The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer

H Wang, X Rong, G Zhao, Y Zhou, Y Xiao… - Cell …, 2022 - pubmed.ncbi.nlm.nih.gov
Immunotherapy has achieved limited success in patients with triple-negative breast cancer
(TNBC), an aggressive disease with a poor prognosis. Commensal microbiota have been …
[HTML] sciencedirect.com

[HTML][HTML] The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer

H Wang, X Rong, G Zhao, Y Zhou, Y Xiao, D Ma, X Jin… - Cell Metabolism, 2022 - Elsevier
Immunotherapy has achieved limited success in patients with triple-negative breast cancer
(TNBC), an aggressive disease with a poor prognosis. Commensal microbiota have been …